Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies

Indian Heart J. 1995 Mar-Apr;47(2):95-105.

Authors

A Avezum Jr¹, P Pais, M D Flather, S Anand, S Yusuf

Affiliation

¹ Division of Cardiology, McMaster University, Hamilton General Hospital, Ontario, Canada.

PMID: 7590849

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / pharmacology
Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Calcium Channel Blockers / pharmacology
Calcium Channel Blockers / therapeutic use
Cardiovascular Agents / pharmacology
Cardiovascular Agents / therapeutic use*
Humans
Myocardial Infarction / drug therapy*
Randomized Controlled Trials as Topic

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers
Cardiovascular Agents